U.S. Sen. Jeanne Shaheen has announced she will be amending financial disclosure forms pursuant to stock options in a breast cancer research company New Hampshire’s Republican State Committee has already called a “shady stick deal.”
“It’s clear that Senator Shaheen provided inaccurate information to the Senate Ethics Committee on her personal financial disclosure form. This error raises questions about a potential conflict of interest involving the Shaheens and their involvement with a company that received federal stimulus funds,” said GOP Committee Chairman Jennifer Horn.
The change involves stock options in Ultrawave Labs Inc., which was “the beneficiary of $78,000 in federal stimulus funding in 2009, the same year William Shaheen, the Democratic senator’s husband, became an adviser to the firm.”
According to Shaheen’s 2013 Senate disclosure form, the options didn’t expire until 2019. Now that the allegedly “shady” deal has come under scrutiny, the Shaheen is claiming they were already expired at the time. Senator Shaheen’s husband William Shaheen “is a partner in Shaheen & Gordon, the prominent Concord legal and lobbying firm, and it set up a “stimulus opportunities team” in 2009, according to the Globe.
Sen. Shaheen voted in favor of President Obama’s stimulus program.”